CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-14 | Fust Matthew K Director | Grant or award | +7,751 | 33,696 | ||
| 2026-05-14 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +14,058 | 14,058 | ||
| 2025-05-15 | Fust Matthew K Director | Grant or award | +5,740 | 25,945 | ||
| 2025-05-15 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +10,787 | 10,787 | ||
| 2024-06-18 | Fust Matthew K Director | Grant or award | +5,345 | 20,205 | ||
| 2024-06-18 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +9,900 | 9,900 | ||
| 2024-03-07 | Fust Matthew K Director | Sale 10b5-1 | −2,550 | $50.89 | $130K | 24,505 |
| 2024-03-07 | Fust Matthew K Director | Sale 10b5-1 | −2,145 | $50.85 | $109K | 22,360 |
| 2024-03-07 | Fust Matthew K Director | Sale 10b5-1 | −7,500 | $50.88 | $382K | 14,860 |
| 2023-06-07 | Fust Matthew K Director | Grant or award | +3,860 | 30,355 | ||
| 2023-06-07 | Fust Matthew K Director | Returned to the company | −3,300 | $51.82 | $171K | 27,055 |
| 2023-06-07 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | ||
| 2022-06-24 | Fust Matthew K Director | Grant or award | +3,300 | 26,495 | ||
| 2022-06-24 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | ||
| 2022-03-04 | Fust Matthew K Director | Exercise or conversion | +7,500 | $40.37 | $303K | 23,195 |
| 2022-03-04 | Fust Matthew K Director | Exercise or conversion · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2021-06-24 | Fust Matthew K Director | Grant or award | +2,145 | 15,695 | ||
| 2021-06-24 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +4,125 | 4,125 | ||
| 2020-07-06 | Fust Matthew K Director | Exercise or conversion | +6,181 | $21.00 | $130K | 19,731 |
| 2020-07-06 | Fust Matthew K Director | Sale | −6,181 | $90.00 | $556K | 13,550 |
Page 1 of 2 · 33 trades